At 12:30 pm today it's not such a good call after all - in fact, according to Tek... IPCI is going to 50 cents... because management F.U. - or is it just F.U.D. - because 50 cents is where he'd like to pick some up.
So much finger pointing and blame... and remarkable how quick the blood-sucking lawyers are, to determine who'se at fault.
My opinion on who is at fault is the committee who never understood what they were there for and went off on a tangent rather than stick to answering the questions the FDA asked for... and the FDA rep... who although she tried... was not able to steer them back on course.
I don't think the FDA has a problem with the blue dye... and only wanted the committee's assessment on whether Rexista met the requirement of being Abuse Deterrent with regards to intravenous use... which I think it did... as the one committee member (Novak) said - well if I answer what the FDA is asking for... the answer is YES.